This is a Study to Verify if Periarticular Hip Injection of Corticosteroid After Partial Hip Replacement Reduce the Pain and the Hospitalisation Time

• Status: Not yet recruiting
• Trial end date: 2023-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators are going to evaluate if periarticular corticosteroid injection during endoprothesis implantation can lead to any advantage to the patients, namely if it can reduce post-operative pain, lenght and cost of hospitalisation, use of analgesics drugs.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Christian Candrian; Ente Ospedaliero Cantonale, Bellinzona
• Treatments: Dexamethasone

Criteria

Inclusion Criteria:

• Patients undergoing unilateral cemented hip endoprosthesis for femoral neck fracture

• Patients aged 50-90 years old

• Patients with a BMI >18.5 and <35

• Patients able to provide informed consent and follow all the study procedures as indicated by the protocol

• Informed Consent as documented by signature

Exclusion Criteria:

• Contraindications to steroids

• Revision endoprosthesis

• Active steroid or immunosuppressive therapy in the last 30 days before the operation

• Pregnant or breast-feeding women

• Presence of other clinically significant concomitant disease states (ASA IV)

• Uncontrolled diabetes mellitus

• Contraindications to NSAIDs

• Chronic systemic diseases as immunodeficiency, autoimmune disease (Systemic Lupus Erythematosus, SLE), gout, rheumatic arthritis

• Known or suspected non-compliance, drug or alcohol abuse

• Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant.

• Participation in another study with investigational drug within the 30 days preceding and during the present study

• Previous enrolment into the current study

• Enrolment of the investigator, his/her family members, employees and other dependent persons.